Cinema Chain Merger Heads for Court Fight
Cineplex accuses Cineworld of "buyer's remorse" and seeking to avoid its obligations under the merger agreement because of the COVID-19 pandemic.
Akorn Files for Chapter 11 After Failed Takeover
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
Perry Ellis Ends Takeover Talks With Randa
The apparent demise of Randa's $460 million proposal clears the way for Perry Ellis to be taken private by founder George Feldenkreis.
Smurfit Spurns International Paper’s New Offer
The Irish packaging firm says the revised proposal "does not make strategic sense" and would expose shareholders to "significantly greater leverage."
Fidelity National Buys Title Insurance Rival
The $1.2 billion purchase of Stewart Information Services will strengthen Fidelity's position as the No. 1 title insurance underwriter in the U.S.
Qualcomm Agrees to Talk With Broadcom
The companies will meet on Wednesday even though Qualcomm has rejected its rival's improved $121 billion takeover offer as inadequate.
CPA Accused of Illegal Trades on Drug Firm News
The former accountant at Celator Pharmaceuticals allegedly passed on tips about market-moving announcements by the company to friends.
Bass Pro Shops Reels in Cabela’s for $5.5B
The merger between two of the largest outdoor gear retailers would add Cabela's 85 stores and "loyal following" to Bass Pro's system.
Pier 1 Counters Hedge Fund With Poison Pill
The retailer follows Alden Global's purchase of a 9.5% stake with a plan to protect shareholders from “coercive or unfair” tactics.
Bayer Clinches Monsanto Takeover for $66B
The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.
Pfizer Makes Cancer Play With Medivation Deal
The $14 billion acquisition would add the best-selling prostate cancer drug Xtandi to Pfizer's growing oncology portfolio.